Moody Aldrich Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-125,497
Closed -$7.95M 162
2021
Q3
$7.95M Buy
125,497
+55,919
+80% +$4.26M 1.01% 43
2021
Q2
$6.37M Buy
+69,578
New +$5.53M 0.89% 49
2019
Q3
Sell
-52,732
Closed -$1.9M 126
2019
Q2
$1.9M Buy
52,732
+1,415
+3% +$45.3K 0.49% 78
2019
Q1
$1.62M Buy
+51,317
New +$1.5M 0.45% 83
2018
Q4
Sell
-117,526
Closed -$3.39M 96
2018
Q3
$3.39M Buy
+117,526
New +$2.2M 0.98% 48

Other funds holding CDNA

Moody Aldrich Partners's CDNA Position: Q4 2021 in Review

Moody Aldrich Partners sold out of CareDx (CDNA) in Q4 2021, closing a stake of 125,497 shares — an estimated $7.95M sold.

Moody Aldrich Partners first reported a position in CDNA in Q3 2018 and held it in 5 quarters. The position peaked at $7.95M in Q3 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

  • Moody Aldrich Partners reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
  • Moody Aldrich Partners sold 125,497 CareDx shares in Q4 2021, an estimated $7.95M.
  • Moody Aldrich Partners first reported a position in CareDx in Q3 2018 and held it in 5 quarters.
  • Moody Aldrich Partners's CareDx position peaked at $7.95M in Q3 2021.
  • 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Moody Aldrich Partners's 13F filing for Q4 2021, filed 2 Feb 2022.